Mastopexy With Autologous Augmentation in Women After Massive Weight Loss - A Clinical, Randomized Study
Primary Purpose
Weight Loss
Status
Completed
Phase
Not Applicable
Locations
Denmark
Study Type
Interventional
Intervention
Rubins Mastopexy
LOPOSAM
Sponsored by
About this trial
This is an interventional treatment trial for Weight Loss focused on measuring Autologous augmentation, Mastopexy, Massive weight loss
Eligibility Criteria
Inclusion Criteria:
- Women that meet the Danish National Board of Health criteria for post bariatric surgery, and is found to be a suitable candidate for autologous augmentation
Exclusion Criteria:
- Severe dementia, making informed consent impossible
- Non-Danish speaking
Sites / Locations
- Odense University Hospital, Department of Plastic and Reconstructive Surgery
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Active Comparator
Arm Label
Rubins Mastopexy
LOPOSAM
Arm Description
Patients are allocated to a mastopexy using Rubins technique
Patients are allocated to a mastopexy using the LOPOSAM technique
Outcomes
Primary Outcome Measures
Operation Time
The time of surgery from start to finish is registered for both techniques.
Secondary Outcome Measures
Costs of treatment
In order to evaluate the socio-economic aspects and cost-benefit associated with the use of each surgical technique we record the following parameters for all patients: Duration of operation, duration of hospitalization, duration of entire course of the breast reconstruction, duration of sick leave and need for revisional/correctional procedures. With these data we can evaluate which technique is the most cost beneficial
Breast measurements
Standardized breast measurements preoperative and at 3, 6 and 12 months postoperative is registered. Measurements registered include sternal notch to nipple distance, breast base and height, projection of the breast and ptosis of the breast, measured with a tape measure.
From this data the investigators can evaluate the long lasting effect of the different techniques
Cosmetic result
The cosmetic result will be evaluated both by the patient on a scale from 1-10 at 3, 6 and 12 months postoperative and by external senior plastic surgeons by evaluating clinical photographs
Complications
Difference in complications between the two techniques will be registered during the follow-up period.They will include: wound dehiscence, partial necrosis, infection and haematoma. Complications will be classified as either major or minor depending on the need for surgical revision
Full Information
NCT ID
NCT02572271
First Posted
October 3, 2015
Last Updated
August 20, 2018
Sponsor
Odense University Hospital
1. Study Identification
Unique Protocol Identification Number
NCT02572271
Brief Title
Mastopexy With Autologous Augmentation in Women After Massive Weight Loss - A Clinical, Randomized Study
Official Title
Mastopexy With Autologous Augmentation in Women After Massive Weight Loss - A Clinical, Randomized Study
Study Type
Interventional
2. Study Status
Record Verification Date
August 2018
Overall Recruitment Status
Completed
Study Start Date
September 2015 (Actual)
Primary Completion Date
November 16, 2017 (Actual)
Study Completion Date
November 16, 2017 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Odense University Hospital
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The purpose of this study is to compare two different techniques of mastopexy with autologous augmentation, the Lower Pole Subglandular Advancement Mastoplasty (LOPOSAM) and Rubins Mastopexy with autologous augmentation, in massive weight loss patients to see if one technique is superior to the other.
Detailed Description
In Massive Weight Loss (MWL) patients the breasts often appear deflated following the prominent volume decrease. The breast is not only deflated, the supportive fibrous tissue is lax and the structural properties have changed. In the typical patient the breast base has sunk along with the inframammary crease and the shape of the breast is wide and flat with a significant ptosis.
One way of helping these women is to offer a mastopexy with autologous augmentation. There are several different surgical techniques for treating the ptotic and deflated breast in MWL patients.
In this study the investigators compare the investigators own technique, LOPOSAM, with Rubins Mastopexy with autologous augmentation.
In Rubins Mastopexy, an extensive re-arrangement of the skin, fat and breast tissue is done and this is supposed to give good long term results. The procedure is however time consuming and extensive.
The LOPOSAM technique is less extensive and therefore less time consuming and the investigators hypothesis is therefore that the technique has a lower complication rate.
Women that is referred for mastopexy after MWL and meet the criteria for post bariatric surgery, set by the Danish National Board of Health, and is found to be a suitable candidate for mastopexy with autologous augmentation is invited to participate in the study.
Sample size assessment has shown that 22 women (11 in each group) is needed and this number of patients is expected to be recruited in 6-9 months.
The study design is a prospective randomized trial.
Preoperative breast measurements and clinical photographs will be compared with measurements and clinical photographs at 3, 6 and 12 months postoperative
The primary outcome is operation time but secondary outcomes include economics, breast measurements, cosmetic result and complication rates.
With this trial, the investigators hope to demonstrate whether or not one of the two techniques is superior to the other and therefore should be the preferred technique.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Weight Loss
Keywords
Autologous augmentation, Mastopexy, Massive weight loss
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
22 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Rubins Mastopexy
Arm Type
Active Comparator
Arm Description
Patients are allocated to a mastopexy using Rubins technique
Arm Title
LOPOSAM
Arm Type
Active Comparator
Arm Description
Patients are allocated to a mastopexy using the LOPOSAM technique
Intervention Type
Procedure
Intervention Name(s)
Rubins Mastopexy
Intervention Description
The surgical technique described by Rubin is performed. No other intervention.
Intervention Type
Procedure
Intervention Name(s)
LOPOSAM
Intervention Description
The surgical technique LOPOSAM is performed. No other intervention.
Primary Outcome Measure Information:
Title
Operation Time
Description
The time of surgery from start to finish is registered for both techniques.
Time Frame
Intraoperative
Secondary Outcome Measure Information:
Title
Costs of treatment
Description
In order to evaluate the socio-economic aspects and cost-benefit associated with the use of each surgical technique we record the following parameters for all patients: Duration of operation, duration of hospitalization, duration of entire course of the breast reconstruction, duration of sick leave and need for revisional/correctional procedures. With these data we can evaluate which technique is the most cost beneficial
Time Frame
1 year
Title
Breast measurements
Description
Standardized breast measurements preoperative and at 3, 6 and 12 months postoperative is registered. Measurements registered include sternal notch to nipple distance, breast base and height, projection of the breast and ptosis of the breast, measured with a tape measure.
From this data the investigators can evaluate the long lasting effect of the different techniques
Time Frame
1 year
Title
Cosmetic result
Description
The cosmetic result will be evaluated both by the patient on a scale from 1-10 at 3, 6 and 12 months postoperative and by external senior plastic surgeons by evaluating clinical photographs
Time Frame
1 year
Title
Complications
Description
Difference in complications between the two techniques will be registered during the follow-up period.They will include: wound dehiscence, partial necrosis, infection and haematoma. Complications will be classified as either major or minor depending on the need for surgical revision
Time Frame
3 months
10. Eligibility
Sex
Female
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Women that meet the Danish National Board of Health criteria for post bariatric surgery, and is found to be a suitable candidate for autologous augmentation
Exclusion Criteria:
Severe dementia, making informed consent impossible
Non-Danish speaking
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Peder Ikander, MD
Organizational Affiliation
Department of Plastic and Reconstructive Surgery, Odense University Hospital, Odense, Denmark
Official's Role
Principal Investigator
Facility Information:
Facility Name
Odense University Hospital, Department of Plastic and Reconstructive Surgery
City
Odense C
ZIP/Postal Code
5000
Country
Denmark
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
19338902
Citation
Rubin JP. Mastopexy after massive weight loss: dermal suspension and total parenchymal reshaping. Aesthet Surg J. 2006 Mar-Apr;26(2):214-22. doi: 10.1016/j.asj.2006.01.010.
Results Reference
background
PubMed Identifier
18061806
Citation
Rubin JP, Khachi G. Mastopexy after massive weight loss: dermal suspension and selective auto-augmentation. Clin Plast Surg. 2008 Jan;35(1):123-9. doi: 10.1016/j.cps.2007.08.008.
Results Reference
background
PubMed Identifier
19083561
Citation
Gusenoff JA, Rubin JP. Plastic surgery after weight loss: current concepts in massive weight loss surgery. Aesthet Surg J. 2008 Jul-Aug;28(4):452-5. doi: 10.1016/j.asj.2008.06.001.
Results Reference
background
PubMed Identifier
19319040
Citation
Rubin JP, Gusenoff JA, Coon D. Dermal suspension and parenchymal reshaping mastopexy after massive weight loss: statistical analysis with concomitant procedures from a prospective registry. Plast Reconstr Surg. 2009 Mar;123(3):782-789. doi: 10.1097/PRS.0b013e31819ba1a8.
Results Reference
background
PubMed Identifier
25255113
Citation
Thoma A, Kaur MN, Tsoi B, Ziolkowski N, Duku E, Goldsmith CH. Cost-effectiveness analysis parallel to a randomized controlled trial comparing vertical scar reduction and inverted T-shaped reduction mammaplasty. Plast Reconstr Surg. 2014 Dec;134(6):1093-1107. doi: 10.1097/PRS.0000000000000751.
Results Reference
background
PubMed Identifier
24987206
Citation
Hansson E, Manjer J, Ringberg A. Inter-observer reliability of clinical measurement of suprasternal notch-nipple distance and breast ptosis. Indian J Plast Surg. 2014 Jan;47(1):61-4. doi: 10.4103/0970-0358.129625.
Results Reference
background
PubMed Identifier
19644246
Citation
Pusic AL, Klassen AF, Scott AM, Klok JA, Cordeiro PG, Cano SJ. Development of a new patient-reported outcome measure for breast surgery: the BREAST-Q. Plast Reconstr Surg. 2009 Aug;124(2):345-353. doi: 10.1097/PRS.0b013e3181aee807.
Results Reference
background
PubMed Identifier
24334499
Citation
Fischer JP, Cleveland EC, Shang EK, Nelson JA, Serletti JM. Complications following reduction mammaplasty: a review of 3538 cases from the 2005-2010 NSQIP data sets. Aesthet Surg J. 2014 Jan 1;34(1):66-73. doi: 10.1177/1090820X13515676. Epub 2013 Dec 13.
Results Reference
background
PubMed Identifier
18777134
Citation
Cardoso MJ, Cardoso JS, Wild T, Krois W, Fitzal F. Comparing two objective methods for the aesthetic evaluation of breast cancer conservative treatment. Breast Cancer Res Treat. 2009 Jul;116(1):149-52. doi: 10.1007/s10549-008-0173-4. Epub 2008 Sep 7.
Results Reference
background
PubMed Identifier
24860932
Citation
Godwin Y, Barron EJ, Edmunds MC, Meyer M, Bardsley A, Logan AM, O'Neill TJ, Wood SH. A comparison of the patient and surgeon opinion on the long-term aesthetic outcome of reduction mammaplasty: have we improved over 15 years? J Plast Reconstr Aesthet Surg. 2014 Jul;67(7):932-8. doi: 10.1016/j.bjps.2014.04.006. Epub 2014 May 9.
Results Reference
background
Links:
URL
http://sundhedsstyrelsen.dk/da/sundhed/kvalitet-og-retningslinjer/nationale-kliniske-retningslinjer/udgivelser/visitationsretningslinjer/~/media/805344BC849E4050857B85345AC14F39.ashx?m=.pdf
Description
The Danish National Board of Health criteria for post bariatric surgery
Learn more about this trial
Mastopexy With Autologous Augmentation in Women After Massive Weight Loss - A Clinical, Randomized Study
We'll reach out to this number within 24 hrs